Avi Shemesh - CREMECOMTRSBI Director
WY52 Stock | EUR 0.16 0.04 33.33% |
Insider
Avi Shemesh is Director of CREMECOMTRSBI DL 001 since 2014.
Age | 56 |
Tenure | 10 years |
Phone | 972-349-3200 |
Web | http://www.cimcommercial.com |
CREMECOMTRSBI Management Efficiency
The company has return on total asset (ROA) of 0.0151 % which means that it generated a profit of $0.0151 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.014 %, meaning that it generated $0.014 on every $100 dollars invested by stockholders. CREMECOMTRSBI's management efficiency ratios could be used to measure how well CREMECOMTRSBI manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
ACA ACA | Great Portland Estates | 49 | |
Jennifer Clark | Office Properties Income | 62 | |
Dan MA | Great Portland Estates | N/A | |
Darren LLB | Great Portland Estates | N/A | |
Ronald Kendall | Easterly Government Properties | 64 | |
Matthew Brown | Office Properties Income | 41 | |
Alison Bernard | Easterly Government Properties | 33 | |
BA MA | Great Portland Estates | N/A | |
Carrie Heiss | Great Portland Estates | N/A | |
Christopher Bilotto | Office Properties Income | 45 | |
MA MA | Great Portland Estates | 54 | |
William Binnie | Easterly Government Properties | 61 | |
BSc BSc | Great Portland Estates | N/A | |
MIOSH AIEMA | Great Portland Estates | N/A | |
Tara Innes | Easterly Government Properties | 61 | |
Anisha BA | Great Portland Estates | N/A | |
ACA LLB | Great Portland Estates | N/A | |
Cynthia Fisher | Easterly Government Properties | 58 | |
Kevin Barry | Office Properties Income | N/A | |
Michael Ibe | Easterly Government Properties | 72 | |
Emil Henry | Easterly Government Properties | 58 |
Management Performance
Return On Equity | 0.014 | |||
Return On Asset | 0.0151 |
CREMECOMTRSBI DL 001 Leadership Team
Elected by the shareholders, the CREMECOMTRSBI's board of directors comprises two types of representatives: CREMECOMTRSBI inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CREMECOMTRSBI. The board's role is to monitor CREMECOMTRSBI's management team and ensure that shareholders' interests are well served. CREMECOMTRSBI's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CREMECOMTRSBI's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jan Salit, President Secretary | ||
Frank Golay, Independent Director | ||
Avi Shemesh, Director | ||
Avraham Shemesh, Director | ||
David Thompson, Chief Executive Officer | ||
Robert Cresci, Independent Director | ||
Kelly Eppich, Independent Director | ||
Douglas Bech, Independent Director | ||
Richard Ressler, Chairman of the Board | ||
Shaul Kuba, Director | ||
Nathan DeBacker, Chief Financial Officer |
CREMECOMTRSBI Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CREMECOMTRSBI a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.014 | |||
Return On Asset | 0.0151 | |||
Profit Margin | 0.06 % | |||
Operating Margin | 0.16 % | |||
Shares Outstanding | 22.74 M | |||
Shares Owned By Insiders | 13.49 % | |||
Shares Owned By Institutions | 59.07 % | |||
Price To Earning | 4.83 X | |||
Revenue | 101.34 M | |||
Gross Profit | 42.62 M |
Currently Active Assets on Macroaxis
Other Information on Investing in CREMECOMTRSBI Stock
CREMECOMTRSBI financial ratios help investors to determine whether CREMECOMTRSBI Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CREMECOMTRSBI with respect to the benefits of owning CREMECOMTRSBI security.